Sharp Mint Limited

Form 483 issued January 31, 2020 · New Delhi, India

Inspection
Jan 27 – Jan 31, 2020
Investigator
Lata Mathew
Observations
5
Pages
6
FEI number
3004293539

In short: On January 31, 2020, FDA issued a Form 483 with 5 observations to Sharp Mint Limited in New Delhi, Delhi (FEI 3004293539) after an inspection that ran Jan 27 – Jan 31, 2020. The investigator was Lata Mathew. Most observations concern laboratory controls and production.

At a glance

Laboratory controls and production account for 3 of 5 observations.

Laboratory controls2
Production1
Materials1
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to implement an on-going stability testing program to monitor the stability characteristics of API, confirm…

  2. 02

    Failure of the QA unit to evaluate the effect of…

  3. 03

    Failure to test the identity of each batch…

  4. 04

    Failure to ensure that all employees…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Sharp Mint Limited?

FDA listed 5 observations on this Form 483, mostly about laboratory controls, production and materials. The opening words of each observation are shown on this page.

Who inspected Sharp Mint Limited?

Lata Mathew is named on this Form 483, for the inspection of Jan 27 – Jan 31, 2020. Each investigator has a profile showing what they cite most.

When was Sharp Mint Limited inspected by FDA?

The inspection ran Jan 27 – Jan 31, 2020, and the Form 483 is dated January 31, 2020.

How do I get the full Form 483 for Sharp Mint Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free